Jenburkt Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 43.07 | 33.94 | 40.03 |
| Operating Expense | 29.79 | 23.25 | 28.99 |
| Net Profit | 9.60 | 7.42 | 7.88 |
| Net Profit Margin | 22.29 | 21.86 | 19.69 |
| Earning Per Share | 21.75 | 16.80 | 17.86 |
| EBIDTA | 13.36 | 10.55 | 11.21 |
| Effective Tax Rate | 22.59 | 23.36 | 24.00 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 43.07 |
| Operating Expense | 29.79 |
| Net Profit | 9.60 |
| Net Profit Margin | 22.29 |
| Earning Per Share | 21.75 |
| EBIDTA | 13.36 |
| Effective Tax Rate | 22.59 |
Invest in Jenburkt Pharmaceuticals Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 141.97 | 136.75 | 123.98 |
| Operating Expenses Annual | 108.85 | 106.38 | 96.73 |
| Operating Profit Annual | 37.79 | 35.49 | 32.20 |
| Interest Annual | 0.27 | 0.37 | 0.43 |
| Depreciation | 2.34 | 2.26 | 1.90 |
| Net Profit Annual | 25.98 | 24.61 | 22.30 |
| Tax Annual | 9.20 | 8.26 | 7.57 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 141.97 |
| Operating Expenses Annual | 108.85 |
| Operating Profit Annual | 37.79 |
| Interest Annual | 0.27 |
| Depreciation | 2.34 |
| Net Profit Annual | 25.98 |
| Tax Annual | 9.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.66 | 5.03 | 2.49 |
| Cash Flow from Operations | 8.12 | 17.05 | 9.27 |
| Cash Flow from Investing | -0.58 | 2.62 | -1.20 |
| Cash Flow from Financing | -7.08 | -21.04 | -5.53 |
| Cash Flow at the End | 4.13 | 3.66 | 5.03 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 3.66 |
| Cash Flow from Operations | 8.12 |
| Cash Flow from Investing | -0.58 |
| Cash Flow from Financing | -7.08 |
| Cash Flow at the End | 4.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 26.62 | 25.95 | 25.97 |
| PBIT Margin (%) | 24.97 | 24.30 | 24.44 |
| PBT Margin (%) | -67.51 | -41.40 | -32.40 |
| Net PROFIT Margin (%) | 18.30 | 18.00 | 17.99 |
| Return On Networth / Equity (%) | 19.44 | 20.53 | 20.66 |
| Return On Networth /Employed (%) | 25.67 | 26.04 | 25.94 |
| Return On Assets (%) | 18.85 | 19.26 | 19.07 |
| Total Debt / Equity (X) | 0.01 | 0.04 | 0.05 |
| Asset Turnover Ratio (%) | 1.03 | 1.07 | 1.06 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 26.62 |
| PBIT Margin (%) | 24.97 |
| PBT Margin (%) | -67.51 |
| Net PROFIT Margin (%) | 18.30 |
| Return On Networth / Equity (%) | 19.44 |
| Return On Networth /Employed (%) | 25.67 |
| Return On Assets (%) | 18.85 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 1.03 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 10.36 | 10.45 | 11.40 |
| Total Current Assets Annual | 109.73 | 81.09 | 75.90 |
| Non Current Assets Annual | 55.37 | 60.72 | 67.05 |
| Total Shareholders Funds Annual | 144.94 | 122.39 | 117.38 |
| Total Assets Annual | 165.10 | 141.81 | 142.95 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 10.36 |
| Total Current Assets Annual | 109.73 |
| Non Current Assets Annual | 55.37 |
| Total Shareholders Funds Annual | 144.94 |
| Total Assets Annual | 165.10 |
No Data Availabe
